# Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI

> **NCT04891874** · NA · COMPLETED · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 76 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** Stereotactic radiotherapy

## Key facts

- **NCT ID:** NCT04891874
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2021-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04891874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04891874, "Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04891874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*